SCHEMBL5578341

SCHEMBL5578341

Nc1c2c(nc3ccc(Br)cc13)N(Cc1ccc(F)cc1)CC2

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.81
ALDH1A1 P00352 6/20 0.81
MAPT P10636 5/20 0.81
LMNA P02545 5/20 0.81
KMT2A Q03164 4/20 0.81
MITF O75030 1/20 0.63
ALPG P10696 1/20 0.63
POLB P06746 3/20 0.53
MEN1 O00255 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
HPGD P15428 2/20 0.51
HTT P42858 1/20 0.51
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
BCHE P06276 10/20 0.49
ACHE P22303 10/20 0.49
GRIN1 Q05586 10/20 0.49
GRIN2A Q12879 10/20 0.49
TSHR P16473 1/20 0.41
RAD52 P43351 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578267 0.90 KDM4E (1.00) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578010 0.85 KDM4E (0.74) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578269 0.85 KDM4E (0.74) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578419 0.85 KDM4E (0.74) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578263 0.84 KDM4E (0.73) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578137 0.82 KDM4E (0.80) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578330 0.82 KDM4E (0.73) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5579198 0.82 KDM4E (0.85) KDM4EALDH1A1MAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL5578125 0.79 KDM4E (0.79) KDM4EALDH1A1MAPTLMNAKMT2A
SCHEMBL5043373 0.75 KDM4E (0.67) KDM4EALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232538-A1 Uses of polypeptides TAKEDA PHARMACEUTICAL COMPANY, LTD (JP) 2007-10-04 US disclosed
US-20040053826-A1 Uses of polypeptides TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-18 US disclosed
EP-1308513-A1 USE OF POLYPEPTIDE Takeda Chemical Industries, Ltd. (JP) 2003-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232538-A1 Uses of polypeptides NPSR1, SCTR, GRPR KDM4E 4438/4885ALDH1A1 3946/4885MAPT 2628/4885
US-20040053826-A1 Uses of polypeptides NPSR1, SCTR, GRPR KDM4E 4438/4885ALDH1A1 3946/4885MAPT 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.